New delhi, Delhi, India
Pharmaceuticals Products - Manufacturer,
Public. Ltd. Firm Since 0
Dabur Pharma Limited is the leading Indian company for cancer research and anticancer products. The company also markets a range of products in the cardiovascular, antibacterial, antidiabetic & digestive segments.
Dabur Pharma Limited, a public limited company incorporated in March 2003, is an associate company of Dabur India Limited, a US $ 250 million healthcare company founded in 1884. Dabur Pharma Limited operates in Europe and in some other markets through its fully owned subsidiary- Dabur Oncology Plc. The Dabur group of companies have a legacy of trust and excellence in the healthcare business.
The fully integrated pharmaceutical business of Dabur Pharma Limited covers the oral & injectable finished dosage forms and active pharmaceutical ingredients & intermediates. The Company has world class expertise for the development and manufacture of active pharmaceutical ingredients, intermediates, and finished dosage forms. This expertise enables it to provide high quality and cost effective pharmaceutical products to markets worldwide.
Dabur Pharma Limited is using the services of Dabur Research Foundation (DRF), for Research & Development activities. DRF is an independent research organization recognized by the Department of Science and Technology, Government of India.
The Company's finished dosage forms are manufactured at most modern manufacturing units in Bordon (U.K.) and Baddi (India), while the active pharmaceutical ingredients (APIs) are manufactured at Kalyani (India). Some of the products are also manufactured by Dabur India Limited at their Sahibabad facilities (India).
The Bordon Facilities have been granted a manufacturing license by the MHRA, UK. These facilities use the unique isolator technology and are one of the best in Europe. The Baddi facilities are approved by the regulatory bodies of countries like Brazil, Colombia, Malaysia, Turkey, Pakistan, Ukraine, Sudan, Belarus Hungary, Jordan, Zimbabwe, Yemen. APIs manufacturing facilities at Kalyani has approvals by TGA, Australia and USFDA.
Manufacturers of Anti-cancer products. Our Products: - Anti-Cancer - Drug-Intermediate - Calcium Regulator - Cyto-Protective - Anti-Emetic - Anti-Histaminic - Expectorant - Vasodilator - Nutritional Supplement - Anti-Thrombotic - Anti-Osteoporotic - Muscle Relaxant - Diagnostic Aid - Analgesic
3, Factory Road,
Adj. Safdarjung Hospital,
New Delhi - 110029 (Delhi) India